Kokad Pharmaceutical Laboratories Limited - Company Profile

It is a pharma public limited company based in Kottayam, Kerala, India, established in 1985.
1985 Kottayam, Kerala, India Active
Last Updated:
About Kokad Pharmaceutical Laboratories Limited

Kokad Pharmaceutical Laboratories Limited, a active public limited company, was established on 02 September 1985 in Kottayam, Kerala, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231KL1985PLC004282. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹5.97 Cr.

It upholds a compliant status. Its leadership includes Rosamma Mathew (Director), Ammu Rose Mathew (Whole-Time Director), Mathew Kokad Thomas (Managing Director). Past directors included Tenish George, Issac John, Jose Kurian. It holds ₹1.61 Cr open charges and ₹6.40 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Mallikassery P Opoovarany Pala, Kottayam, Kerala, 686577.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231KL1985PLC004282

  • Registration Number

    004282

  • Incorporation Date

    02 September 1985

  • Authorized Capital

    ₹15.00 Cr

  • Paid-Up Capital

    ₹5.97 Cr

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 5.97 Cr
  • Company Age 40 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.61 Cr
  • Satisfied Charges ₹ 6.40 Cr
  • Revenue Growth **** -99.92%
  • Profit Growth **** 99.64%
  • Ebitda **** 99.87%
  • Net Worth 99.90%
  • Total Assets -99.91%
Company report

Kokad Pharmaceutical Laboratories Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kokad Pharmaceutical Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kokad Pharmaceutical Laboratories Limited?
Current Directors
Name Designation Appointment Date Status
Rosamma Mathew Director 10 Jun 2005 Current
Ammu Rose Mathew Whole-Time Director 22 Sep 2017 Current
Mathew Kokad Thomas Managing Director 02 Sep 1985 Current
Thomas Mathew Kokad Whole-Time Director 29 Sep 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Feb 2021 Past
Pramod Abcsdd Director 02 Aug 2014 Past
Pramod Abcsdd Director 22 Mar 2014 Past
Pramod Abcsdd Director 15 Mar 2008 Past
Pramod Abcsdd Director 15 Feb 2021 Past
Pramod Abcsdd Whole-Time Director 03 Sep 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kokad Pharmaceutical Laboratories.

Kokad Pharmaceutical Laboratories Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.92% decrease. The company also saw a substantial improvement in profitability, with a 99.64% increase in profit. The company's net worth Soared by an impressive increase of 99.9%.

Kokad Pharmaceutical Laboratories revenue growth over time
Kokad Pharmaceutical Laboratories profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-99.92%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
-99.91%
*******
*******
*******
*******
Profit or Loss
*******
99.64%
*******
*******
*******
*******
Net Worth
*******
99.90%
*******
*******
*******
*******
EBITDA
*******
99.87%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kokad Pharmaceutical Laboratories?

In 2021, Kokad Pharmaceutical Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹16,050,000.00

Satisfied Charges

₹63,950,000.00

Charges Breakdown by Lending Institutions
  • Kerala Financial Corporation : 2.79 Cr
  • State Bank Of Travacore : 2.00 Cr
  • Kerala State Financial Enterprises Ltd : 1.61 Cr
Latest Charge Details
Date Lender Amount Status
18 Aug 2018 Kerala State Financial Enterprises Ltd ₹1.61 Cr Satisfied
25 Mar 2004 Kerala Financial Corporation ₹1.25 Cr Satisfied
17 Jul 1999 State Bank Of Travacore ₹1.20 Cr Satisfied
12 Mar 1996 Kerala Financial Corporation ₹1.37 Cr Satisfied
30 Oct 1993 State Bank Of Travacore ₹7.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Kokad Pharmaceutical Laboratories?

Unlock and access historical data on people associated with Kokad Pharmaceutical Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kokad Pharmaceutical Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kokad Pharmaceutical Laboratories's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kokad Pharmaceutical Laboratories
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Kokad Pharmaceutical Laboratories Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    The activity Thomas Mathew Kokad was appointed as a Whole-time director was appointed as a Whole-time director on 29 Sep 2025 & has been associated with this company since 5 months 12 days . was completed.

  • Charges

    A charge registered on 18 Aug 2018 via Charge ID 100206453 with Kerala State Financial Enterprises Ltd was fully satisfied on 11 Jun 2025. was recorded as a recent event.

  • Balance Sheet

    Progress on Kokad Pharmaceutical Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was documented.

  • Charges

    The activity A charge registered on 25 Mar 2004 via Charge ID 90019729 with Kerala Financial Corporation was fully satisfied on 23 Aug 2018. was completed.

  • Charges

    Progress on A charge registered on 12 Mar 1996 via Charge ID 90016557 with Kerala Financial Corporation was fully satisfied on 23 Aug 2018. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kokad Pharmaceutical Laboratories Limited?

The CIN of Kokad Pharmaceutical Laboratories Limited is U24231KL1985PLC004282.

Where is Kokad Pharmaceutical Laboratories Limited headquartered?

Kokad Pharmaceutical Laboratories Limited is headquartered at Mallikassery P Opoovarany Pala, Kottayam, Kerala, 686577.

When was Kokad Pharmaceutical Laboratories Limited incorporated?

Kokad Pharmaceutical Laboratories Limited was incorporated on 02 September 1985.

Who are the current directors of Kokad Pharmaceutical Laboratories Limited?

The current directors of Kokad Pharmaceutical Laboratories Limited are

What is the primary industry of Kokad Pharmaceutical Laboratories Limited?

The primary industry of Kokad Pharmaceutical Laboratories Limited is Manufacturing.

Is Kokad Pharmaceutical Laboratories Limited a listed company?

Kokad Pharmaceutical Laboratories Limited is unlisted.

What is the capital structure of Kokad Pharmaceutical Laboratories Limited?

The authorized capital of Kokad Pharmaceutical Laboratories Limited is ₹15.00 Cr, and the paid-up capital is ₹5.97 Cr.

What is the compliance status of Kokad Pharmaceutical Laboratories Limited?

The compliance status of Kokad Pharmaceutical Laboratories Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available